Clinical Trial: A Randomized, Open-label, Controlled Clinical Study to Evaluate the Safety and Immunogenicity of Adsorbed Acellular Diphtheria, Tetanus and Pertussis Combined Vaccine Administered at Different Injection Sites in Healthy Infants and Young Children (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Open-label, Controlled Clinical Study to Evaluate the Safety and Immunogenicity of Adsorbed Acellular Diphtheria, Tetanus and Pertussis Combined Vaccine Administered at Different Injection Sites in Healthy Infants and Young Children'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130480

Registration Time: 2026/08/20

Type: Interventional study

Primary Sponsor: Hubei Provincial Center for Disease Control and Prevention

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333356

Published by HT Digital Content Services with permission from Healt...